Susan Denman

Susan Denman is a seasoned executive with extensive experience in board service and advisory roles across various organizations. Currently, Denman serves as a Member at Extraordinary Women on Boards and as Chief Executive Officer & Managing Partner of Susan Denman Group LLC, providing strategic advisory services and executive coaching. Denman's recent roles include Digital Advisory Board Member at Sage Therapeutics, Member of the Board of Directors at Spinal Elements, Senior Advisor at Kohlberg & Company, and Advisory Board Member at Trinity Life Sciences. Furthermore, Denman's impressive tenure at Johnson & Johnson and Sanofi demonstrates expertise in digital transformation, marketing strategy, and product commercialization. Denman holds an MBA in Marketing and Finance from The Wharton School and a BA in Economics and German from Duke University, along with additional education from prestigious programs at MIT and Academy of St. Elizabeth.